Can a one-item mood scale do the trick? Predicting relapse over 5.5-years in recurrent depression.

<h4>Background</h4>To examine whether a simple Visual Analogue Mood Scale (VAMS) is able to predict time to relapse over 5.5-years.<h4>Methodology/principal findings</h4>187 remitted recurrently depressed out-patients were interviewed using the Structured Clinical Interview f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gerard D van Rijsbergen, Claudi L H Bockting, Matthias Berking, Maarten W J Koeter, Aart H Schene
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e9c5a022427c49a3a350a73ae48bdb5f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:<h4>Background</h4>To examine whether a simple Visual Analogue Mood Scale (VAMS) is able to predict time to relapse over 5.5-years.<h4>Methodology/principal findings</h4>187 remitted recurrently depressed out-patients were interviewed using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the 17-item Hamilton Depression rating scale (HAM-D) to verify remission status (HAM-D <10). All patients rated their current mood with the help of a Visual Analogue Mood Scale (VAMS) at baseline and at a follow-up assessment three months later. Relapse over 5.5-years was assessed by the SCID-I. Cox regression revealed that both the VAMS at baseline and three months later significantly predicted time to relapse over 5.5-years. Baseline VAMS even predicted time to relapse when the number of previous depressive episodes and HAM-D scores were controlled for. The baseline VAMS explained 6.3% of variance in time to relapse, comparable to the HAM-D interview.<h4>Conclusions/significance</h4>Sad mood after remission appears to play a pivotal role in the course of depression. Since a simple VAMS predicted time to relapse, the VAMS might be an easy and time-effective way to monitor mood and risk of early relapse, and offers possibilities for daily monitoring using e-mail and SMS.<h4>Trial registration</h4>International Standard Randomized Controlled Trial Register Identifier: ISRCTN68246470.